» Articles » PMID: 25450261

Contribution of Bioinformatics Prediction in MicroRNA-based Cancer Therapeutics

Overview
Specialty Pharmacology
Date 2014 Dec 3
PMID 25450261
Citations 21
Authors
Affiliations
Soon will be listed here.
Abstract

Despite enormous efforts, cancer remains one of the most lethal diseases in the world. With the advancement of high throughput technologies massive amounts of cancer data can be accessed and analyzed. Bioinformatics provides a platform to assist biologists in developing minimally invasive biomarkers to detect cancer, and in designing effective personalized therapies to treat cancer patients. Still, the early diagnosis, prognosis, and treatment of cancer are an open challenge for the research community. MicroRNAs (miRNAs) are small non-coding RNAs that serve to regulate gene expression. The discovery of deregulated miRNAs in cancer cells and tissues has led many to investigate the use of miRNAs as potential biomarkers for early detection, and as a therapeutic agent to treat cancer. Here we describe advancements in computational approaches to predict miRNAs and their targets, and discuss the role of bioinformatics in studying miRNAs in the context of human cancer.

Citing Articles

MGAT4EP promotes tumor progression and serves as a prognostic marker for breast cancer.

Zhong L, Zhu J, Chen J, Jin X, Liu L, Ji S Cancer Biol Ther. 2025; 26(1):2475604.

PMID: 40069131 PMC: 11901376. DOI: 10.1080/15384047.2025.2475604.


The Impact of COVID-19 on RNA Therapeutics: A Surge in Lipid Nanoparticles and Alternative Delivery Systems.

Parvin N, Mandal T, Joo S Pharmaceutics. 2024; 16(11).

PMID: 39598489 PMC: 11597542. DOI: 10.3390/pharmaceutics16111366.


A Bioinformatics-Based Approach to Discover Novel Biomarkers in Hepatocellular Carcinoma.

Shourideh A, Maddah R, Amiri B, Basharat Z, Shadpirouz M Iran J Public Health. 2024; 53(6):1332-1342.

PMID: 39430152 PMC: 11488550.


Lymph node metastasis determined miRNAs in esophageal squamous cell carcinoma.

Wei F, Bi S, Li M, Yu J Aging (Albany NY). 2024; 16(20):13104-13116.

PMID: 39401765 PMC: 11552642. DOI: 10.18632/aging.206122.


Significance of as a biomarker for clinical prognosis, immune infiltration, and drug therapy in lung squamous cell carcinoma.

Lin H, Wang J, Shi Q, Wu M PeerJ. 2024; 12:e17338.

PMID: 38708353 PMC: 11069361. DOI: 10.7717/peerj.17338.


References
1.
Li W, LeBrun D, Li M . The expression and functions of microRNAs in pancreatic adenocarcinoma and hepatocellular carcinoma. Chin J Cancer. 2011; 30(8):540-50. PMC: 4013404. DOI: 10.5732/cjc.011.10197. View

2.
Voorhoeve P, le Sage C, Schrier M, Gillis A, Stoop H, Nagel R . A genetic screen implicates miRNA-372 and miRNA-373 as oncogenes in testicular germ cell tumors. Cell. 2006; 124(6):1169-81. DOI: 10.1016/j.cell.2006.02.037. View

3.
Bittner M, Meltzer P, Chen Y, Jiang Y, Seftor E, Hendrix M . Molecular classification of cutaneous malignant melanoma by gene expression profiling. Nature. 2000; 406(6795):536-40. DOI: 10.1038/35020115. View

4.
Landgraf P, Rusu M, Sheridan R, Sewer A, Iovino N, Aravin A . A mammalian microRNA expression atlas based on small RNA library sequencing. Cell. 2007; 129(7):1401-14. PMC: 2681231. DOI: 10.1016/j.cell.2007.04.040. View

5.
Gomes C, Cho J, Hood L, Franco O, Pereira R, Wang K . A Review of Computational Tools in microRNA Discovery. Front Genet. 2013; 4:81. PMC: 3654206. DOI: 10.3389/fgene.2013.00081. View